Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers

BACKGROUND: Hospitals in the Middle East Gulf region have experienced an influx of COVID-19 patients to their medical wards and intensive care units. The hypercoagulability of these patients has been widely reported on a global scale. However, many of the experimental treatments used to manage the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Atallah, Bassam, El Nekidy, Wasim, Mallah, Saad I., Cherfan, Antoine, AbdelWareth, Laila, Mallat, Jihad, Hamed, Fadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479301/
https://www.ncbi.nlm.nih.gov/pubmed/32922212
http://dx.doi.org/10.1186/s12959-020-00236-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479301/
https://www.ncbi.nlm.nih.gov/pubmed/32922212
http://dx.doi.org/10.1186/s12959-020-00236-9

Ejemplares similares